TNGX
Tango Therapeutics, Inc. · Healthcare
President, R&D Adam Crystal sold $618K of Tango Therapeutics, Inc.
Sold$617,571
$22.87Price
27,000Shares
−19%Stake
What TNGX did after the filing
- The stock from Thu, Jun 4 open, $21.47
- +28.3%
- S&P 500, same days
- −1.3%
Measured over 30 trading days, to the Jul 20 close.
Traded Mon, Jun 1. Filed Wed, Jun 3, 6:37 PM ET, after the close. Returns use the Jun 4 open and the Jul 20 close. Not investment advice.